Ardehali M Behfar, Anselmo Anthony, Cochrane Jesse C, Kundu Sharmistha, Sadreyev Ruslan I, Kingston Robert E
Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.
Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Mol Cell. 2017 Dec 7;68(5):872-884.e6. doi: 10.1016/j.molcel.2017.10.025. Epub 2017 Nov 16.
Polycomb repressive complex 2 (PRC2-EZH2) methylates histone H3 at lysine 27 (H3K27) and is required to maintain gene repression during development. Misregulation of PRC2 is linked to a range of neoplastic malignancies, which is believed to involve methylation of H3K27. However, the full spectrum of non-histone substrates of PRC2 that might also contribute to PRC2 function is not known. We characterized the target recognition specificity of the PRC2 active site and used the resultant data to screen for uncharacterized potential targets. The RNA polymerase II (Pol II) transcription elongation factor, Elongin A (EloA), is methylated by PRC2 in vivo. Mutation of the methylated EloA residue decreased repression of a subset of PRC2 target genes as measured by both steady-state and nascent RNA levels and perturbed embryonic stem cell differentiation. We propose that PRC2 modulates transcription of a subset of low expression target genes in part via methylation of EloA.
多梳抑制复合物2(PRC2-EZH2)使组蛋白H3的赖氨酸27位点(H3K27)发生甲基化,并且在发育过程中维持基因抑制状态是必需的。PRC2的失调与一系列肿瘤恶性肿瘤有关,这被认为涉及H3K27的甲基化。然而,PRC2的非组蛋白底物的完整谱可能也对PRC2功能有贡献,目前尚不清楚。我们表征了PRC2活性位点的靶标识别特异性,并利用所得数据筛选未表征的潜在靶标。RNA聚合酶II(Pol II)转录延伸因子Elongin A(EloA)在体内被PRC2甲基化。通过稳态和新生RNA水平测量,甲基化EloA残基的突变降低了PRC2靶基因子集的抑制作用,并扰乱了胚胎干细胞分化。我们提出,PRC2部分地通过EloA的甲基化来调节低表达靶基因子集的转录。